Search research articles
Contact Us
Filters
Showing results (131-140 of 163) with videos related to
Page
of 17
Sort By:
Annals of Hematology
|
May 1, 1995
Primary non-Hodgkin's lymphoma of the vagina. Case report and review of the literature
H G Höffkes, A Schumann, M Uppenkamp, et al.
Oncology
|
May 1, 1996
Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients
M Knippschild, E N Schmid, M Uppenkamp, et al.
Leukemia
|
April 30, 2004
Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome
C Schrader, P Meusers, G Brittinger, et al.
Experimental Hematology
|
November 10, 1998
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy
S Kasimir-Bauer, H Ottinger, P Meusers, et al.
Krankenpflege Journal
|
April 1, 1987
[AIDS--watching or acting? A memorandum by the physicians in charge of the Center for Internal Medicine, the Essen University Hospital]
K D Bock, G Brittinger, H Goebell, et al.
Blood
|
August 1, 1986
Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia
U Dührsen, M Uppenkamp, I Uppenkamp, et al.
British Journal of Cancer
|
September 29, 2005
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma
C Schrader, D Janssen, W Klapper, et al.
Annals of Internal Medicine
|
September 1, 1992
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group
W Siegert, A Agthe, H Griesser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy
M Engelhard, P Meusers, G Brittinger, et al.
Onkologie
|
February 1, 1989
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study]
H H Gerhartz, W Wilmanns, G Brittinger, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 163) with videos related to
Sort By:
Page
of 17
Annals of Hematology
|
May 1, 1995
Primary non-Hodgkin's lymphoma of the vagina. Case report and review of the literature
H G Höffkes, A Schumann, M Uppenkamp, et al.
Oncology
|
May 1, 1996
Infection by Alcaligenes xylosoxidans subsp. xylosoxidans in neutropenic patients
M Knippschild, E N Schmid, M Uppenkamp, et al.
Leukemia
|
April 30, 2004
Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome
C Schrader, P Meusers, G Brittinger, et al.
Experimental Hematology
|
November 10, 1998
In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy
S Kasimir-Bauer, H Ottinger, P Meusers, et al.
Krankenpflege Journal
|
April 1, 1987
[AIDS--watching or acting? A memorandum by the physicians in charge of the Center for Internal Medicine, the Essen University Hospital]
K D Bock, G Brittinger, H Goebell, et al.
Blood
|
August 1, 1986
Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia
U Dührsen, M Uppenkamp, I Uppenkamp, et al.
British Journal of Cancer
|
September 29, 2005
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma
C Schrader, D Janssen, W Klapper, et al.
Annals of Internal Medicine
|
September 1, 1992
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group
W Siegert, A Agthe, H Griesser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy
M Engelhard, P Meusers, G Brittinger, et al.
Onkologie
|
February 1, 1989
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study]
H H Gerhartz, W Wilmanns, G Brittinger, et al.
Page
of 17